Regis Healthcare (ASX:REG) Is Up 7.6% After Funding Expansion From Cash Flow Amid Margin Pressures – Has The Bull Case Changed?

Simply Wall St.

02/24

Regis Healthcare Limited (ASX:REG) reported half-year 2025 results showing revenue of A$744.7 million, up from A$622.8 million a year earlier, while net income fell to A$13.4 million from A$24.4 ...

网页链接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2613659007"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2613659007\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2613659007?lang=zh_TW&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","is_english":true,"pubTime":"2026-02-24 09:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2613659007","market":"nz","top_or_hot":-1,"title":"Regis Healthcare (ASX:REG) Is Up 7.6% After Funding Expansion From Cash Flow Amid Margin Pressures – Has The Bull Case Changed?","media":"Simply Wall St.","content":"<div>\n<p>Regis Healthcare Limited (ASX:REG) reported half-year 2025 results showing revenue of A$744.7 million, up from A$622.8 million a year earlier, while net income fell to A$13.4 million from A$24.4 ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-asxreg-is-up-76-after-funding-expansion-fro\">网页链接</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regis Healthcare (ASX:REG) Is Up 7.6% After Funding Expansion From Cash Flow Amid Margin Pressures – Has The Bull Case Changed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegis Healthcare (ASX:REG) Is Up 7.6% After Funding Expansion From Cash Flow Amid Margin Pressures – Has The Bull Case Changed?\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Simply Wall St.</strong><span class=\"h-time small\">2026-02-24 09:20</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>Regis Healthcare Limited (ASX:REG) reported half-year 2025 results showing revenue of A$744.7 million, up from A$622.8 million a year earlier, while net income fell to A$13.4 million from A$24.4 ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-asxreg-is-up-76-after-funding-expansion-fro\">网页链接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-asxreg-is-up-76-after-funding-expansion-fro\">Simply Wall St.</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4080","symbol_name":"零售業房地產投資信託","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-asxreg-is-up-76-after-funding-expansion-fro","article_id":"2613659007","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-asxreg-is-up-76-after-funding-expansion-fro","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2613659007","pubTimestamp":1771896045,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Regis Healthcare Limited (ASX:REG) reported half-year 2025 results showing revenue of A$744.7 million, up from A$622.8 million a year earlier, while net income fell to A$13.4 million from A$24.4 million amid funding-related margin pressures.\nManagement highlighted stronger operating cash generation, the reintroduction of RAD retention for new residents and a strong balance sheet as foundations to actively pursue further acquisitions and greenfield developments in aged care.\nWe will now...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4080":"零售业房地产投资信托","BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR","BK4231":"零售房地产信托","REG.AU":"REGIS HEALTHCARE LTD","LABU":"三倍做多标普生物-Direxion","BK4588":"碎股","BK4585":"ETF&股票定投概念","REG":"Regency Centers Corp","XBI":"SPDR S&P Biotech ETF","BK7113":"保健护理机构"},"translate_title":"Regis Healthcare(ASX：REG)在利润率压力下通过现金流为扩张提供资金后上涨7.6%——牛市情况发生变化了吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"REG":1.5,"XBI":0.6,"LABU":0.6,"REG.AU":1.5},"content_text":"Regis Healthcare Limited (ASX:REG) reported half-year 2025 results showing revenue of A$744.7 million, up from A$622.8 million a year earlier, while net income fell to A$13.4 million from A$24.4 million amid funding-related margin pressures. Management highlighted stronger operating cash generation, the reintroduction of RAD retention for new residents and a strong balance sheet as foundations to actively pursue further acquisitions and greenfield developments in aged care. We will now examine how Regis’ plan to fund acquisitions and greenfield developments from operating cash flow could influence its investment narrative. Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.AdvertisementRegis Healthcare Investment Narrative RecapTo own Regis Healthcare, you need to believe that structural demand for aged care, funding reforms and portfolio growth can outweigh current funding related margin pressure. The latest half year result reinforces that the near term catalyst remains execution on acquisitions and greenfield projects funded from operating cash flow, while the biggest risk is that rising care and staffing costs continue to compress margins. On balance, this update does not materially change either the key catalyst or the principal risk. The most relevant recent announcement is management’s plan to use substantial operating cash flow, supported by net RAD inflows and a strong balance sheet, to pursue further acquisitions and greenfield developments. This ties directly into the growth catalyst of expanding bed capacity and improving asset quality, but it also brings the risk that higher capex and acquisition spend could pressure free cash flow and returns if operating performance or occupancy do not track expectations. However, investors should also be aware that if care minute requirements and wage pressures keep rising faster than future funding adjustments, then... Read the full narrative on Regis Healthcare (it's free!)Regis Healthcare's narrative projects A$1.5 billion revenue and A$99.0 million earnings by 2028. This requires 9.6% yearly revenue growth and an A$50.0 million earnings increase from A$49.0 million today.Uncover how Regis Healthcare's forecasts yield a A$7.98 fair value, a 15% upside to its current price.Exploring Other PerspectivesASX:REG 1-Year Stock Price Chart Five fair value estimates from the Simply Wall St Community span from A$7.29 to A$294.37 per share, showing how far apart individual views can be. Against this wide spread, the current focus on funding related margin pressure and cost inflation risk gives you important context for thinking about how Regis’ performance could evolve and why it is worth comparing several viewpoints before forming your own view.Explore 5 other fair value estimates on Regis Healthcare - why the stock might be a potential multi-bagger!Reach Your Own ConclusionDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Regis Healthcare research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.Our free Regis Healthcare research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Regis Healthcare's overall financial health at a glance.Contemplating Other Strategies?Opportunities like this don't last. These are today's most promising picks. Check them out now:The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.AI is about to change healthcare. These 10 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.Uncover the next big thing with 59 elite penny stocks that balance risk and reward.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}